APAC
Acute pain market seen rising 12% annually on surgical demand
Acute pain market seen rising 12% annually on surgical demand
It was valued at $4.5b in 2025.
4 days ago
Bioinformatics market set to hit $34.41b on genomics boom
Asia Pacific is expected to register the highest growth rate.
6 days ago
Global GLP-1 market on track for $133.92b by 2034
Asia Pacific is projected to post the fastest regional growth.
6 days ago
Demand for custom implants to push market to $11.5b by 2036
Orthopaedic implants lead the market.
Preventive health propels biotics supplements to $6.2b by 2036
Capsules are projected to dominate the market.
AI, handheld imaging to drive ultrasound-on-chip market growth
It is expected to reach $200.5m by 2036.
Rising chronic illness drives point of care testing market to $31b mark
Asia Pacific is poised to see the strongest expansion.
Rising radiation safety demand to drive medical detection market to $2.22b
Hospitals accounted for 71.7% of the market in 2025.
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Despite this, few companies in the region have scaled globally.
DNA diagnostics market to reach $24.7b by 2034 on precision medicine, genomic advancements
Asia-Pacific emerges as a key growth region.
Asia-Pacific nations roll out WHO framework on air, health risks
Eleven governments launched WHO-backed efforts to strengthen health-based policymaking.
How can healthcare providers make AI pay off?
Most organisations are still breaking even on technology spending.
Label identification technologies market to reach $2.87b by 2031
Asia Pacific is expected to be the fastest-growing regional market.
Hospital demand and AI drive $10b expansion in MRI market in 2036
Hospitals are investing in AI reconstruction to improve scanner utilisation.
Body fluid analysis market to hit $3.65b on neurological and cancer demand
Speciality diagnostics widen across multiple body fluid categories in hospital laboratories.
Global diabetes trials market to double to $10b by 2034
AI-enabled decentralised clinical trials are forecast to grow at a 10.5% CAGR.
Global dialysis market to hit $141.5b by 2031
Asia Pacific is set to register the highest regional CAGR.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings